Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

被引：1
|
作者：
Kow, Chia Siang [1 ]
Hasan, Syed Shahzad [2 ,3 ]
机构：
[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia
[2] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2021年 / 19卷 / 01期
关键词：
ANTIHYPERTENSIVE DRUGS; OUTCOME INCIDENCE; RISK; ANGIOEDEMA;
D O I：
10.1080/14779072.2021.1842050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [1] Response to the letter to the editor entitled 'Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic'
    Bottino, Leonardo Grabinski
    Fuchs, Flavio Danni
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2021, 19 (02) : 189 - 190
  • [2] The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension
    Li, Mingfei
    Wang, Ying
    Ndiwane, Ndindam
    Orner, Michelle B.
    Palacios, Natalia
    Mittler, Brant
    Berlowitz, Dan
    Kazis, Lewis E.
    Xia, Weiming
    PLOS ONE, 2021, 16 (03):
  • [3] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
    Benenson, Irina
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
  • [4] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
  • [5] COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    St John, Megan H.
    Barry, Arden R.
    CANADIAN PHARMACISTS JOURNAL, 2020, 153 (04) : 193 - 197
  • [6] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Li, Xiao-Long
    Li, Tao
    Du, Qi-Cong
    Yang, Li
    He, Kun-Lun
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5462 - 5469
  • [7] Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis
    Sadria, Mehrshad
    Layton, Anita T.
    PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (10)
  • [8] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
    Simko, Fedor
    Baka, Tomas
    CLINICAL SCIENCE, 2021, 135 (08) : 1009 - 1014
  • [9] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
    Xiao Meng
    Ya Liu
    Chenchen Wei
    Kai Zhang
    Yi Zhang
    Ming Zhong
    Cheng Zhang
    Yun Zhang
    Science China(Life Sciences) , 2021, (05) : 836 - 839
  • [10] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
    Meng, Xiao
    Liu, Ya
    Wei, Chenchen
    Zhang, Kai
    Zhang, Yi
    Zhong, Ming
    Zhang, Cheng
    Zhang, Yun
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (05) : 836 - 839
12345